Correlation Between Marfrig Global and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Marfrig Global and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marfrig Global and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marfrig Global Foods and Esperion Therapeutics, you can compare the effects of market volatilities on Marfrig Global and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marfrig Global with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marfrig Global and Esperion Therapeutics.

Diversification Opportunities for Marfrig Global and Esperion Therapeutics

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Marfrig and Esperion is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Marfrig Global Foods and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Marfrig Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marfrig Global Foods are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Marfrig Global i.e., Marfrig Global and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Marfrig Global and Esperion Therapeutics

Assuming the 90 days horizon Marfrig Global Foods is expected to generate 1.55 times more return on investment than Esperion Therapeutics. However, Marfrig Global is 1.55 times more volatile than Esperion Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  265.00  in Marfrig Global Foods on December 1, 2024 and sell it today you would earn a total of  15.00  from holding Marfrig Global Foods or generate 5.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Marfrig Global Foods  vs.  Esperion Therapeutics

 Performance 
       Timeline  
Marfrig Global Foods 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Marfrig Global Foods has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Marfrig Global is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Esperion Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Esperion Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Marfrig Global and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Marfrig Global and Esperion Therapeutics

The main advantage of trading using opposite Marfrig Global and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marfrig Global position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind Marfrig Global Foods and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world